SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-16-108727
Filing Date
2016-03-30
Accepted
2016-03-30 16:33:59
Documents
12
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a16-7174_110k.htm 10-K 3053334
2 EX-21.1 a16-7174_1ex21d1.htm EX-21.1 11990
3 EX-23.1 a16-7174_1ex23d1.htm EX-23.1 3499
4 EX-31.1 a16-7174_1ex31d1.htm EX-31.1 9932
5 EX-31.2 a16-7174_1ex31d2.htm EX-31.2 9979
6 EX-32.1 a16-7174_1ex32d1.htm EX-32.1 6309
7 GRAPHIC g71741bi03i001.jpg GRAPHIC 39182
8 GRAPHIC g71741bi03i002.jpg GRAPHIC 29796
9 GRAPHIC g71741bi13i001.jpg GRAPHIC 76382
10 GRAPHIC g71741bi19i001.gif GRAPHIC 1165
11 GRAPHIC g71741fri001.gif GRAPHIC 73
12 GRAPHIC g71741bi01i001.gif GRAPHIC 26895
  Complete submission text file 0001104659-16-108727.txt   3335927
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37686 | Film No.: 161540129
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences